Purdue Pharma, Sacklers' OxyContin settlement lands at the Supreme Court
Under the deal, Purdue agreed it owed $8 billion in criminal and civil fines. That deal that is at the center of Monday's case because it releases the Sacklers from personal liability.
The opioid crisis comes to the Supreme Court Monday as the justices hear arguments in a challenge to the bankruptcy deal meant to compensate victims of the highly addictive pain killer OxyContin.
Under the terms of the deal approved by a lower court, Purdue Pharma—the maker, aggressive peddler, and deceptive marketer of Oxycontin— agreed to pay billions of dollars to those harmed in the opioid epidemic. In exchange, the deal shields members of the Sackler family from personal liability, though they owned and ran the company.
Just what happened at Purdue Pharma,.
